Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

Lignende værker

• QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model
  af: Kalra, Jessica, et al.
  Udgivet: (2009)
• Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas
  af: Zhang, Yi-wang, et al.
  Udgivet: (2014)
• Oncogenic and tumor-suppressive mouse models for breast cancer engaging HER2/neu
  af: Fry, Elizabeth A., et al.
  Udgivet: (2016)
• Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3.
  af: Wallasch, C, et al.
  Udgivet: (1995)
• HER 2/neu protein expression in colorectal cancer
  af: Zielinski Ch, et al.
  Udgivet: (2006-05-01)